Conversely, EMP 3 is downregulated in neuroblastoma [45], glioma [45], non-small cell lung cancer (NSCLC) [46], and esophageal cancer [47], where it inhibits cell proliferation. This evidence concerns the gene EMP3 and neuroblastoma.